Cation Exchange Resin Achieves Higher Dynamic Binding Capacity
Tosoh Bioscience adds TOYOPEARL Sulfate-650F, a strong cation exchange resin that exhibits high salt tolerance, to its process media product line.
Tosoh Bioscience, a provider of chromatographic resins for the purification of biopharmaceutical drugs in commercial manufacturing processes, introduced TOYOPEARL Sulfate-650F, a strong cation exchange resin that exhibits a high salt tolerance, for sale in the Americas. TOYOPEARL Sulfate-650F resin allows for lowered operating costs by offering higher dynamic binding capacities for IgG. This resin can achieve a dynamic binding capacity of >120 g/L of monoclonal antibody (mAb) and exhibits pressure-flow properties at 30 cm inner diameter of up to 500 cm/hr (0.2 MPa). The resin is ideal for applications performed in physiological conditions or for post-protein A removal of aggregates. According to the company, the chromatographic resin captures mAb aggregates over a wide pH range without losing its binding capacity for mAb, resulting in higher resolution between monomer and aggregates.
Source: Tosoh Bioscience
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.
